Authors


Alexandra M. Trevino, MD, Northwestern Medicine
Alexandra M. Trevino, MD

Latest:

Disparities in Pregnancy-Related Hypertension Among Hispanic Subgroups: Alexandra M. Trevino, MD

Alexandra M. Trevino, MD, of Northwestern Medicine presented the oral abstract, "Trends in New-Onset Hypertensive Disorders of Pregnancy Among US Adults by Place of Birth and Hispanic Ethnic Origin Group," on day 1 of the ASPC Congress on CVD Prevention.


Craig Nelson, MA

Latest:

Leveraging Longitudinal Clinical Laboratory Results to Improve Prenatal Care

Collaboration between a clinical laboratory and a managed care organization improved prenatal care and outcomes through real-time, actionable, laboratory-derived insights and care coordination.


Morgan A. Henderson, PhD

Latest:

Cross-Validation of Insurer and Hospital Price Transparency Data

Real-world cross-validation of insurer and hospital price transparency data finds low overlap but high concordance between data sources.


Erica Chilson, PharmD

Latest:

Hospital Discharge Diagnosis Position: Impact on Adult Pneumonia Burden Estimates

Disease burden estimates of pneumonia-associated hospitalizations are more sensitive when including pneumonia coded in any diagnosis field vs in only the first discharge diagnosis field.


Alvin W. Su, MD, PhD

Latest:

Adolescent Anterior Cruciate Ligament Reconstruction: A Decade of Rising Surgical Cost

Adolescent anterior cruciate ligament reconstruction surgery can preserve health and restore function of the knee joint, but the surgical cost has outpaced inflation.


Thomas Kingsley, MD

Latest:

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

The authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.


Nameera Temkar, MD

Latest:

Combination of Magrolimab and Rituximab Well Tolerated in Patients With Refractory/Relapsed Indolent NHL

A 3-year follow-up of patients with refractory/relapsed indolent non-Hodgkin (NHL) treated with a combination of magrolimab and rituximab showed no new treatment-emergent adverse events, suggesting long-term safety. The treatment also confirmed magrolimab penetration into the tumor.


Oren J. Mechanic, MD, MPH

Latest:

TeleConnect: Digitally Connecting Physicians Across the Health Care System

TeleConnect introduces the concept of connecting primary care physicians and specialists by leveraging technology. Improving communication in a health care system betters patient care.


Paloma Mohn

Latest:

Responsibility for Treating Tobacco Dependence in Health Clinics Serving Medicaid Enrollees

This article describes the implementation of Medicaid smoking cessation guidance in a large, urban federally qualified health center to examine how state-level provisions translated into clinic-level policies.


John P. Kansky, MSE, MBA

Latest:

Assessment of Structured Data Elements for Social Risk Factors

An expert panel identified and assessed electronic health record and health information exchange structured data elements to support future development of social risk factor computable phenotyping.


Jay T. Rubinstein, MD, PhD

Latest:

Gene Therapy Holds Potential in Otoferlin-Related Hearing Loss

Jay T. Rubinstein, MD, PhD, University of Washington School of Medicine, discusses DB-OTO, an investigational gene therapy with potential to treat otoferlin gene–related hearing loss.


Anthony M. DiGiorgio, DO, MHA

Latest:

Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury

Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.


Abigail Brooks, MA

Latest:

FDA Reviewing Sotatercept-csrk Label Expansion for PAH

Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.


Alexandra Polovneff, BS

Latest:

Scaling Care Coordination Through Digital Engagement: Stepped-Wedge Trial Assessing Readmissions

This evaluation looks at a postdischarge digital engagement (PDDE) program using causal inference methods to examine the impact of PDDE on readmission.


Hannah Fullington, MPH

Latest:

Characteristics of Self-Triaged Emergency Department Visits by Adults With Cancer

Adults with cancer may have difficulty self-assessing the clinical severity of their acute care needs, yet they rarely use a telephone triage line available to them.


Keanan Lane, MPP

Latest:

How State Surprise Billing Protections Increased ED Visits, 2007-2018: Potential Implications for the No Surprises Act

State surprise billing protections decreased emergency department (ED) out-of-pocket payments to such an extent that ED visits actually increased.


Anna Zink, PhD

Latest:

Artificial Intelligence in Medicare: Utilization, Spending, and Access to AI-Enabled Clinical Software

This study quantified the trends over time in utilization of, spending on, and access to CT fractional flow reserve, the first artificial intelligence (AI)–enabled clinical software reimbursed by Medicare.


Heather Saunders, PhD, MSW

Latest:

Health Plan Switching and Satisfaction in a Medicaid MLTSS Program

Health plan dissatisfaction was higher among Medicaid managed long-term services and supports (MLTSS) beneficiaries who did not follow through with an intention to change health plans.


Carole E. Aubert, MD, MSc

Latest:

Evaluating Alternative Methods of Comparing Antihypertensive Treatment Intensity

Medication dose captures modification of hypertension treatment intensity more precisely than medication count, and this measure should be preferred in studies that aim to improve hypertension management.


Peter Reaven, MD

Latest:

Cost Savings From an mHealth Tool for Improving Medication Adherence

The Wellth smartphone app significantly increased medication adherence and lowered unnecessary health care utilization and costs over 9 months among Medicaid beneficiaries who were self-managing chronic conditions.


Asher Perzigian
Asher Perzigian

Latest:

Contributor: The Complexity Concern in Value-Based Care

This is the fifth and final article in a series on value-based care and the 4 challenges health care organizations must overcome.


Jewel Jackson

Latest:

Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori Infection

For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.


Farbod Alinezhad, MD, MPH

Latest:

Impact of Hospital-Physician Integration on Medicare Patient Mix

This study found no evidence that hospital employment of physicians resulted in physicians treating sicker patients, undercutting claims that hospital-employed physicians serve a higher-acuity patient mix.


Erik Muther, BA

Latest:

Assessing Opportunities to Advance Quality Measures in Adult Obesity

Obesity is a serious chronic disease and risk factor for a broad range of outcomes. This study identifies opportunities for improving quality in obesity care.


Marilyn Heng, MD, MPH

Latest:

Discharge Prescribing and Subsequent Opioid Use After Traumatic Musculoskeletal Injury

The authors use surgical resident assignment as an instrumental variable for discharge opioid prescribing and estimate the impact of discharge opioid supply on subsequent use.


Jon F. Oliver, PhD

Latest:

Projected US Savings From Biosimilars, 2021-2025

Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.


Max Weiss, BA

Latest:

Tacking Upwind: Reducing Spending Among High-risk Commercially Insured Patients

Although commercial accountable care organization populations are healthy on average, some individuals might benefit from programs for high-risk patients to mitigate high levels of health care utilization.


Kjel A. Johnson, PharmD

Latest:

Using Telemedicine Interventions During COVID-19 to Expand Care Post COVID-19

The Patient-Centered Rheumatology Collaborative identified several critical areas for further intervention to improve the delivery of high-quality, patient-centered care during the COVID-19 pandemic and beyond.


Nicholas Bouchard, PharmD

Latest:

The Future of IV and Subcutaneous Therapies in Oncology

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with patient-specific factors guiding delivery method choices, while ongoing innovation and collaboration drive the growing integration of SubQ formulations as a convenient and adaptable option in cancer care.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo